Title: Atherosclerotic Cardiovascular Disease Awareness Month

Summary: Designates February 2023 as "Atherosclerotic Cardiovascular Disease Awareness Month" in Florida.

Full Text:
WHEREAS, approximately million individuals in the United States have been diagnosed with atherosclerotic cardiovascular disease (ASCVD), making them at risk for a cardiovascular event, and WHEREAS, ASCVD is lin ked to the build-up of cholesterol in the arteries, and the risk of associated events can be modified by lowering low-density lipoprotein cholesterol (LDL-C), and WHEREAS, in 2016, nearly million adults in the United States had higher than recommended LDL-C levels, and WHEREAS, approximately 43.1 million Americans are being treated with lipid-lowering therapies to manage cardiovascular risk, and WHEREAS, a study conducted by the University of California found that only percent of people with ASCVD who were taking statins, one of the leading lipid-lowering therapies, achieved healthy levels of LDL-C, and WHEREAS, as of 2019, an estimated million adults in Florida have been diagnosed or informed by a health professional WHEREAS, Centers for Disease Control and Prevention (CDC) data for that same year shows that an estimated million Floridians have experienced a heart attac kand more than 700,000 Floridians have experienced a stroke in their lifetime, and WHEREAS, CDC data shows that in 2019, the effects of ASCVD were reported as underlying causes of death for 34,781 Floridians, NOW, THEREFORE, Be It Resolved by the Hous eof Representatives of the State of Florida: That February 2023 is designated as "Atherosclerotic Cardiovascular Disease Awareness Month" in Florida.